Micelle BioPharma Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Micelle BioPharma General Information

Description

Developer of lipid drug delivery technology designed to enhance the bioavailability of lipophilic active pharmaceutical ingredients. The company's technology focuses on developing and marketing a variety of products, enabling patients to improve the body's ability to break down and use lipophilic compounds such as fatty acids, hormones, several vitamins, and many active pharmaceutical ingredients.

Contact Information

Formerly Known As
Sancilio & Company
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 3874 Fiscal Court
  • Suite 100
  • Riviera Beach, FL 33404
  • United States
+1 (561)
Primary Industry
Drug Delivery
Vertical(s)
Corporate Office
  • 3874 Fiscal Court
  • Suite 100
  • Riviera Beach, FL 33404
  • United States
+1 (561)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Micelle BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Bankruptcy: Admin/Reorg 05-Nov-2018 Completed Bankruptcy: Admin/Reorg
12. Later Stage VC 19-Jan-2018 Completed Generating Revenue
11. IPO 16-Sep-2016 Cancelled Generating Revenue
10. Debt - General 01-Feb-2016 Completed Generating Revenue
9. Debt - General 18-Dec-2014 Completed Generating Revenue
8. Later Stage VC (Series C) 18-Jul-2014 Completed Generating Revenue
7. Debt Repayment 20-Dec-2013 Completed Generating Revenue
6. Debt - General 27-Aug-2013 Completed Generating Revenue
5. Later Stage VC (Series B) 01-Mar-2012 $2M $9.5M Completed Generating Revenue
4. Later Stage VC (Series A) 30-Jan-2012 $7.5M $7.5M Completed Generating Revenue
To view Micelle BioPharma’s complete valuation and funding history, request access »

Micelle BioPharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 106,964 $0.010000 $71.78 $71.78 1x $0.72 42.79%
To view Micelle BioPharma’s complete cap table history, request access »

Micelle BioPharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of lipid drug delivery technology designed to enhance the bioavailability of lipophilic active pharmaceutical
Drug Delivery
Riviera Beach, FL
200 As of 2017

Morristown, NJ
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Micelle BioPharma Competitors (10)

One of Micelle BioPharma’s 10 competitors is Capsugel, a Private Equity-Backed company based in Morristown, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Capsugel Private Equity-Backed Morristown, NJ
CordenPharma Private Equity-Backed Basel, Switzerland
Esperion Therapeutics Private Equity-Backed Ann Arbor, MI
Ropack Pharma Solutions Corporation Montreal, Canada
ABIONYX Pharma Formerly VC-backed Balma, France
You’re viewing 5 of 10 competitors. Get the full list »

Micelle BioPharma Patents

Micelle BioPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3212236-A1 Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states Inactive 10-Oct-2014
WO-2016057915-A1 Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states Inactive 10-Oct-2014
ES-2741560-T3 Compositions of omega-3 fatty acid esters Active 30-Mar-2012
JP-2015514083-A Omega-3 fatty acid ester composition Active 30-Mar-2012
JP-6359517-B2 Omega-3 fatty acid ester composition Inactive 30-Mar-2012 A61K47/22
To view Micelle BioPharma’s complete patent history, request access »

Micelle BioPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Micelle BioPharma FAQs

  • When was Micelle BioPharma founded?

    Micelle BioPharma was founded in 2006.

  • Where is Micelle BioPharma headquartered?

    Micelle BioPharma is headquartered in Riviera Beach, FL.

  • What is the size of Micelle BioPharma?

    Micelle BioPharma has 200 total employees.

  • What industry is Micelle BioPharma in?

    Micelle BioPharma’s primary industry is Drug Delivery.

  • Is Micelle BioPharma a private or public company?

    Micelle BioPharma is a Private company.

  • What is Micelle BioPharma’s current revenue?

    The current revenue for Micelle BioPharma is .

  • How much funding has Micelle BioPharma raised over time?

    Micelle BioPharma has raised $49.2M.

  • Who are Micelle BioPharma’s competitors?

    Capsugel, CordenPharma, Esperion Therapeutics, Ropack Pharma Solutions, and ABIONYX Pharma are some of the 10 competitors of Micelle BioPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process